{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:32:24Z","timestamp":1790674344199,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shanghai Pujiang program","award":["17PJ1408200"],"award-info":[{"award-number":["17PJ1408200"]}]},{"name":"Shanghai Public Health Clinical Center","award":["KY-GW-2017-17"],"award-info":[{"award-number":["KY-GW-2017-17"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.micinf.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T16:45:57Z","timestamp":1505925957000},"page":"648-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide"],"prefix":"10.1016","volume":"19","author":[{"given":"Peng","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2017.09.004_bib1","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/emi.2016.75","article-title":"Sustained live poultry market surveillance contributes to early warnings for human infection with avian influenza viruses","volume":"5","author":"Fang","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib2","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1038\/emi.2016.69","article-title":"Intense circulation of A\/H5N1 and other avian influenza viruses in Cambodian live-bird markets with serological evidence of sub-clinical human infections","volume":"5","author":"Horm","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib3","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1038\/emi.2016.121","article-title":"Avian H11 influenza virus isolated from domestic poultry in a Colombian live animal market","volume":"5","author":"Jimenez-Bluhm","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib4","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/emi.2015.14","article-title":"The diversity of avian influenza virus subtypes in live poultry markets before and during the second wave of A(H7N9) infections in Hangzhou, China","volume":"4","author":"Li","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib5","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1038\/emi.2015.63","article-title":"Avian influenza A(H7N9) virus and mixed live poultry-animal markets in Guangdong province: a perfect storm in the making?","volume":"4","author":"Zhou","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2017.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.27.30568","article-title":"Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017","volume":"22","author":"Kang","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.micinf.2017.09.004_bib8","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1038\/emi.2016.127","article-title":"First documented case of avian influenza (H5N1) virus infection in a lion","volume":"5","author":"Chen","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib9","first-page":"490","article-title":"PA-356R is a unique signature of the avian influenza A (H7N9) viruses with bird-to-human transmissibility: potential implication for animal surveillances","volume":"67","author":"Xu","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jiw414","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults","volume":"214","author":"Madan","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.09.004_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1099\/jgv.0.000365","article-title":"Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines","volume":"97","author":"He","year":"2016","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2017.09.004_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.micinf.2014.11.003","article-title":"Adenovirus-based vaccines against avian-origin H5N1 influenza viruses","volume":"17","author":"He","year":"2015","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1038\/emi.2016.64","article-title":"Intranasal application of polyethyleneimine suppresses influenza virus infection in mice","volume":"5","author":"He","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib14","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2017.06.044","article-title":"Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I\/II, prospective, randomized, open-label trial","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/14760584.2016.1203261","article-title":"Recombinant hemagglutinin influenza vaccine provides broader spectrum protection","volume":"15","author":"Dunkle","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2017.09.004_bib16","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2017.09.004_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2017.09.004_bib18","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"Influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2017.09.004_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.micinf.2017.09.004_bib20","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1128\/JVI.03101-13","article-title":"Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model","volume":"88","author":"Price","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.09.004_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.09.004_bib22","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/emi.2016.51","article-title":"Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B","volume":"5","author":"Gong","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A\u00a0universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2017.09.004_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02462-16","article-title":"Recombinant adenoviruses displaying matrix 2 ectodomain epitopes on their fiber proteins as universal influenza vaccines","volume":"91","author":"Tang","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.09.004_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","article-title":"N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication","volume":"35","author":"Liu","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.micinf.2017.09.004_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.intimp.2004.12.005","article-title":"The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection","volume":"5","author":"Zou","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.micinf.2017.09.004_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1574-695X.2008.00402.x","article-title":"Fine-epitope mapping of an antibody that binds the ectodomain of influenza matrix protein 2","volume":"53","author":"Zou","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.micinf.2017.09.004_bib29","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/emi.2015.22","article-title":"An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus","volume":"4","author":"Leung","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib30","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1016\/j.vaccine.2015.05.053","article-title":"A\u00a0lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate","volume":"33","author":"Zeng","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib31","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib32","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.vaccine.2008.11.037","article-title":"Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib33","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1016\/j.vaccine.2009.04.075","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2017.09.004_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"Holsinger","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.09.004_bib36","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.2174\/13816128113199990337","article-title":"Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors","volume":"19","author":"Petukhova","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.micinf.2017.09.004_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib38","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2017.06.001","article-title":"Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge","volume":"509","author":"Deng","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.09.004_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.03.003","article-title":"Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge","volume":"93","author":"Liu","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.micinf.2017.09.004_bib41","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","author":"Eliasson","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.micinf.2017.09.004_bib42","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1016\/j.vaccine.2014.08.030","article-title":"Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib43","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2008.05.087","article-title":"A\u00a0clinical trial examining the effect of increased total CRM(197) carrier protein dose on the antibody response to Haemophilus influenzae type b CRM(197) conjugate vaccine","volume":"26","author":"Usonis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.09.004_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4161\/hv.7.11.17984","article-title":"Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants","volume":"7","author":"Ruiz-Palacios","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.micinf.2017.09.004_bib46","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.vaccine.2016.06.039","article-title":"Preclinical studies on new proteins as carrier for glycoconjugate vaccines","volume":"34","author":"Tontini","year":"2016","journal-title":"Vaccine"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791730148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791730148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T13:12:40Z","timestamp":1701177160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645791730148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S128645791730148X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2017.09.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}